Market Signals CoreWeave $9 Billion Bid Is ‘Dead in the Water’

BloombergWednesday, October 29, 2025 at 5:29:10 PM
Market Signals CoreWeave $9 Billion Bid Is ‘Dead in the Water’
CoreWeave Inc.'s ambitious $9 billion merger with Core Scientific Inc. is facing significant challenges as market signals suggest the deal may not go through. With a crucial shareholder vote approaching, the uncertainty surrounding this merger raises concerns about the future of both companies and their strategic plans. This situation is important as it highlights the volatility in the tech and data center sectors, impacting investors and stakeholders alike.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
CoreWeave just kicked open a billion-dollar door
PositiveFinancial Markets
CoreWeave is making waves in the AI cloud industry by turning GPU scarcity into a lucrative business model. Backed by Nvidia, they offer a comprehensive solution that combines capacity, software, and support for customers needing high-performance AI on demand. This innovative approach not only addresses the growing demand for AI resources but also positions CoreWeave as a key player in a billion-dollar market, highlighting the importance of adaptability in technology.
MEG Again Delays Vote on Cenovus Deal Over Regulatory Issue
NegativeFinancial Markets
MEG Energy Corp. has once again delayed the announcement of the results from its shareholder vote regarding the acquisition by Cenovus Energy Inc. This postponement, attributed to a last-minute regulatory inquiry, raises concerns about the deal's future and highlights the complexities companies face in navigating regulatory landscapes. Such delays can impact investor confidence and the overall market perception of both companies involved.
Core Scientific Deal With CoreWeave Terminated After Failing to Secure Shareholder Support
NegativeFinancial Markets
Core Scientific's planned $9 billion all-stock merger with CoreWeave has fallen through after the company couldn't secure the necessary shareholder votes. This outcome is significant as it allows Core Scientific to remain a public entity, but it also raises questions about its future strategies and financial stability in a challenging market.
Shareholders reject $9bn CoreWeave offer for Core Scientific
NegativeFinancial Markets
Shareholders have rejected a $9 billion offer from CoreWeave for Core Scientific, which could significantly impact CoreWeave's growth plans and its soaring stock price. This decision highlights the challenges faced by companies in the tech sector as they navigate complex financial landscapes and investor expectations.
Core Scientific terminates $9 billion purchase offer from CoreWeave after shareholder vote
NegativeFinancial Markets
Core Scientific has decided to terminate its $9 billion purchase offer from CoreWeave following a shareholder vote. This decision is significant as it reflects the challenges and complexities involved in large-scale acquisitions, especially in the tech sector. The outcome may impact both companies' futures and their strategic directions, highlighting the importance of shareholder opinions in corporate decisions.
CoreWeave to acquire AI development platform Marimo
PositiveFinancial Markets
CoreWeave's acquisition of the AI development platform Marimo marks a significant step in enhancing its capabilities in artificial intelligence. This move not only strengthens CoreWeave's position in the tech industry but also promises to accelerate innovation in AI development, making advanced tools more accessible to developers. As AI continues to shape various sectors, this acquisition is a strategic play that could lead to groundbreaking advancements and opportunities for both companies.
Core Scientific stockholders reject merger with CoreWeave
NegativeFinancial Markets
Core Scientific stockholders have voted against the proposed merger with CoreWeave, a decision that could significantly impact the future of both companies. This rejection highlights the ongoing challenges in the tech and cryptocurrency sectors, where investor confidence is crucial. The outcome raises questions about Core Scientific's strategic direction and its ability to compete in a rapidly evolving market.
Daily market wrap: Fiserv, CoreWeave, and Palantir lead
PositiveFinancial Markets
The stock market saw a positive shift as the three major indices closed on a mixed note, following the Federal Reserve's announcement of a rate cut. This news is significant as it reflects the Fed's efforts to stimulate economic growth, which can lead to increased investor confidence and potentially higher stock prices. Companies like Fiserv, CoreWeave, and Palantir are at the forefront of this market movement, indicating a robust interest in tech and financial sectors.
Latest from Financial Markets
Cracks in the Credit Market Could Be a Warning for Wall Street
NegativeFinancial Markets
Recent developments in the credit market are raising alarms for Wall Street, suggesting potential instability ahead. The metaphor of cockroaches sinking a ship highlights the concern that small issues can lead to larger problems in financial systems. This matters because it could signal a downturn in the economy, affecting investments and consumer confidence.
Bloomberg Brief 10/31/2025 (Video)
NeutralFinancial Markets
The Bloomberg Brief for October 31, 2025, provides a comprehensive overview of the latest developments in finance and markets. This video highlights key trends and insights that are shaping the economic landscape, making it essential for investors and analysts to stay informed. Understanding these updates can help individuals and businesses make better financial decisions.
LendInvest Secured Income II reports £39m in eligible loans for Q3 2025
PositiveFinancial Markets
LendInvest Secured Income II has reported an impressive £39 million in eligible loans for the third quarter of 2025. This significant figure highlights the growing confidence in the property finance market and showcases LendInvest's strong position in providing accessible funding solutions. As the demand for loans continues to rise, this achievement not only reflects the company's robust performance but also signals a positive trend for investors looking for reliable opportunities in the financial sector.
Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential
PositiveFinancial Markets
Connect Biopharma has received a Buy rating from BTIG, highlighting the company's promising potential in the respiratory drug market. This endorsement is significant as it suggests confidence in the company's innovative approaches and could attract more investors, boosting its stock performance. The focus on respiratory treatments is particularly timely given the ongoing global health challenges, making this development noteworthy for both the company and its stakeholders.
UBS lowers Zillow Group stock price target to $92 from $95, keeps Buy rating
NeutralFinancial Markets
UBS has adjusted its price target for Zillow Group's stock from $95 to $92 while maintaining a 'Buy' rating. This change reflects UBS's analysis of the current market conditions and Zillow's performance. Investors should note that despite the lowered target, the 'Buy' rating suggests confidence in Zillow's long-term potential.
AppLovin stock price target lowered to $664 by BTIG on mixed feedback
NegativeFinancial Markets
AppLovin's stock price target has been lowered to $664 by BTIG, reflecting mixed feedback from analysts. This adjustment highlights concerns about the company's performance and market perception, which could impact investor confidence and future growth prospects.